WHO/MAP/IND/02 Pivotal study to evaluate the immunogenicity and safety of a measles vaccine given by aerosolized inhalation: randomized controlled trial.

Trial Profile

WHO/MAP/IND/02 Pivotal study to evaluate the immunogenicity and safety of a measles vaccine given by aerosolized inhalation: randomized controlled trial.

Completed
Phase of Trial: Phase II/III

Latest Information Update: 01 Sep 2016

At a glance

  • Drugs Measles virus vaccine live (Primary) ; Measles virus vaccine live (Primary)
  • Indications Measles
  • Focus Adverse reactions; Pharmacodynamics; Registrational
  • Sponsors Serum Institute of India
  • Most Recent Events

    • 03 May 2011 Status changed from active, no longer recruiting to completed, as reported in the Clinical Trials Registry - India record.
    • 04 May 2010 Status changed from recruiting to active, no longer recruiting, as reported in the Clinical Trials Registry - India record.
    • 10 Mar 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top